Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2003
12/11/2003WO2003102097A1 The hydrochloride of (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
12/11/2003WO2003101969A1 Multi-substituded imidazolines and method of use thereof
12/11/2003WO2003101968A1 Pyrazole compound and medicinal composition containing the same
12/11/2003WO2003101964A1 Piperidine derivative, process for producing the same, and use
12/11/2003WO2003101961A1 Novel substituted indoles
12/11/2003WO2003101959A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases
12/11/2003WO2003101956A1 Pharmaceutical combination
12/11/2003WO2003101954A2 Nf-kb inhibitors and uses thereof
12/11/2003WO2003101933A1 Intermediate products, methods for their preparation and use thereof
12/11/2003WO2003101452A1 Process for the preparation of highly pure rabeprazole sodium salt
12/11/2003WO2003101444A1 Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer
12/11/2003WO2003101442A1 Peptide deformylase inhibitors
12/11/2003WO2003087090A3 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
12/11/2003WO2003062280A3 Water-soluble dithioesters and method for polymerization thereof
12/11/2003WO2003059903A3 Substituted 4-aminopyridine derivatives used as pest control agents
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003028721A3 Substituted benzimidazole compounds and their use for the treatment of cancer
12/11/2003WO2003024926A3 Methods and compositions of novel triazine compounds
12/11/2003WO2002100825A3 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances
12/11/2003WO2002088114A3 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
12/11/2003WO2002085925A3 Melanocortin receptor ligands
12/11/2003US20030229229 Anticancer agents; kinase inhibitors; antiallergens; autoimmune disease; rheumatic diseases; skin disorders
12/11/2003US20030229133 Amidine inhibitors of serine proteases
12/11/2003US20030229125 Herbicidal substituted pyridines, their preparation, and their use as herbicides and plant growth regulators
12/11/2003US20030229123 2-(Substituted-phenyl)amino-imidazoline derivatives
12/11/2003US20030229121 Antihistamines, antiallergens, skin disorders, antiinflammatory agents
12/11/2003US20030229118 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation
12/11/2003US20030229110 Cell signal transduction
12/11/2003US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
12/11/2003US20030229100 Anticholesterol agents; antidiabetic agents; hypotensive agents
12/11/2003US20030229099 Novel farnesyl protein transferase inhibitors as antitumor agents
12/11/2003US20030229097 Potentiation of fungicides
12/11/2003US20030229095 Sexual disorders
12/11/2003US20030229094 Acetamides and benzamides that are useful in treating sexual dysfunction
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229089 Cyclic compounds
12/11/2003US20030229085 1-Phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
12/11/2003US20030229084 Osteoporosis; antiarthritic agents
12/11/2003US20030229081 Antiinflammatory agents, antiischemic agents, malaria, Crohn's disease, skin disorders
12/11/2003US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
12/11/2003US20030229077 Nitrogen-containing heterocyclic compounds
12/11/2003US20030229076 Therapy for psychological disorders; cardiovascular disorders; antidiabetic agents; central nervous system disorders
12/11/2003US20030229074 Metabolism; eating disorders; sexual disorders
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030229069 1-Sulfonyl-4-aminoalkoxy indole derivatives and uses thereof
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229058 Aryl aniline beta2 adrenergic receptor agonists
12/11/2003US20030229054 Novel amines as pharmaceutical agents
12/11/2003US20030229050 Insecticidal anthranilamides
12/11/2003US20030229025 Antidiabetic agents, eating disorders, dietetics
12/11/2003US20030228982 Substituted phenyl derivatives
12/11/2003US20030228978 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
12/11/2003US20030226216 Novel 6-alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibres
12/11/2003CA2487688A1 Piperidine derivative, process for producing the same, and use
12/11/2003CA2487675A1 Novel substituted indoles
12/11/2003CA2487659A1 Intermediate products, methods for their preparation and use thereof
12/11/2003CA2486110A1 Pharmaceutical combination
12/11/2003CA2482838A1 Pyrazole compounds and pharmaceutical compositions containing the compound
12/10/2003EP1369420A1 Inhibitors of the GPib - vWF interaction
12/10/2003EP1369419A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
12/10/2003EP1369418A1 Quinazoline derivatives
12/10/2003EP1368342A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/10/2003EP1368341A1 Phenyl derivatives 3
12/10/2003EP1368340A1 Piperazine derivatives as melanocortin receptor agonists
12/10/2003EP1368339A1 Substituted piperidines/piperazines as melanocortin receptor agonists
12/10/2003EP1368338A1 Method of preparing lansoprazole and its intermediate
12/10/2003EP1368337A2 Piperazine derivatives and their use as 5-ht1b ligands
12/10/2003EP1368326A2 Oxazolidinone photoaffinity probes
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368323A1 Pyrimidine matrix metalloproteinase inhibitors
12/10/2003EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368032A1 Excitatory amino acid receptor antagonists
12/10/2003EP1368031A2 Method of treating of demyelinating diseases or conditions
12/10/2003EP1368028A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
12/10/2003EP1367893A1 Pyridyl pyrimidines for use as pesticides
12/10/2003EP1115721B1 Pyrimidone derivatives
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461303A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1130358C Imidzzole compounds and preparing method and application thereof
12/10/2003CN1130351C 1,5-benzodiazepine derivatives
12/10/2003CN1130347C 2,3-methylene amino acid compounds, their preparing method and pharmaceutical composition containing them
12/10/2003CN1130345C Amino quinoline derivatives
12/09/2003US6660864 Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
12/09/2003US6660859 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003US6660753 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
12/09/2003US6660751 Sulfonamide derivatives as 5-HT7 receptor antagonists
12/09/2003US6660746 Cardiovascular disorders
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660739 Heterocyclic amides as inhibitors of factor Xa
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
12/09/2003US6660736 MAO-B inhibitors
12/09/2003US6660733 Induce immunology response
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660731 Pyrazole compounds useful as protein kinase inhibitors
12/09/2003CA2189593C Sulphonylaminocarbonyltriazolinones having substituents bonded via oxygen
1 ... 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 ... 1080